The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 40.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 3.00 (7.50%)
Open: 41.50
High: 41.50
Low: 41.50
Prev. Close: 41.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ALUSID Wins Prestigious IChemE Award

4 Nov 2016 11:00

RNS Number : 3734O
Frontier IP Group plc
04 November 2016
 

 

 

 

AIM: FIPP

RNS Reach

4 November 2016

 

Frontier IP Group Plc ("Frontier IP")

 

Portfolio News - ALUSID Wins Prestigious Institution of Chemical Engineers (IChemE) Award

 

Frontier IP, which specialises in the commercialisation of intellectual property, is pleased to announce that its portfolio company Alusid Limited ("ALUSID") has been awarded this year's IChemE Global Award 2016 for Best Business Start-Up against a shortlist of international nominees, which included businesses from the UK, USA and New Zealand.

The full text of the announcement made by ALUSID is set out below.

ALUSID is delighted to announce that it has won this year's IChemE Global Award 2016 for Best Business Start-Up. The IChemE awards celebrate excellence, innovation and achievement in the chemical, biochemical and process industries.

ALUSID is based in Preston, Lancashire, where it manufactures SilicaStone® - an eco-architectural material made from 100% recycled glass and vitrified ceramic that would otherwise end up in landfill. Its unique, patent pending, process allows for materials to be created without the use of resin, cement or other binders, making it fire and heat resistant as well as making it recyclable at the end of its life.

SilicaStone® was designed as a uniquely adaptable alternative to natural stone products for use as feature walls for interiors and exterior cladding or as solid surfaces. It can be colored and finished in a variety of different shapes and textures all of which are UV stable and durable.

ALUSID is currently working on the design of an automated production plant with a major Italian tile equipment manufacturer in preparation for considerably upscaling production.

Dr Alasdair Bremner, Operations Manager at Alusid, said: "To be recognised in such a strong field for this prestigious award is fantastic. For our work to be recognised for its innovation is testament to the dedication, enthusiasm and commitment of our team in creating a new benchmark for sustainability in construction and architecture."

 

Neil Crabb, Director, Alusid said "It is extremely satisfying to have secured this engineering award for a product which is manufactured from recycled materials, in a low environmental impact manufacturing process that produces zero waste, at a time when ethical manufacturing and sourcing is increasingly important for large corporations and public contracts."

 

Notes

ALUSID - a university spinoff company - was born from a research project led by Professor David Binns and Dr Alasdair Bremner, at the University of Central Lancashire. The company aims to be a leader in the supply of premium engineered sustainable architectural materials and remains at the forefront of this growing sector through continuous research and development.

 

Website: www.alusid.co.uk

High resolution Images are available for download from our website http://www.alusid.co.uk/press-media/

The Institution of Chemical Engineers (IChemE) is the global professional membership organisation for chemical engineering professionals and anyone involved with the process industries, including the emerging bioprocess sector. It has over 44,000 members in over 120 countries. The IChemE awards were held at The Palace Hotel Manchester on Thursday the 3rd of November 2016.

 

ENDS

 

 

Enquiries

 

Frontier IP Group Plc

T: 0131 240 1251

Neil Crabb, Chief Executive

Company website: www.frontierip.co.uk

 

Cantor Fitzgerald Europe

(Nominated Adviser and Joint Broker)

T: 020 7894 7000

David Foreman, Catherine Leftley, Corporate Finance

David Banks, Sales

Peterhouse Corporate Finance Limited

(Joint Broker)

T: 020 7469 0935

Lucy Williams

Kreab

T: 020 7074 1800

Robert Speed, Matthew Jervois

 

 

Notes to Editor:

 

About Frontier IP Group plc

www.frontierip.co.uk 

Frontier IP specialises in assisting institutions and companies in the commercialisation and exploitation of their intellectual property. It establishes formal and informal relationships with sources of exploitable IP, principally universities. Its core business is building and growing a portfolio of equity stakes in spin-out companies by taking an active involvement in the commercialisation and funding of these businesses.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFSEFSLFMSEIF
Date   Source Headline
28th Jul 20205:22 pmRNSHolding(s) in Company
22nd Jul 202012:50 pmRNSHolding(s) in Company
21st Jul 20209:05 amRNSSecond Price Monitoring Extn
21st Jul 20209:00 amRNSPrice Monitoring Extension
21st Jul 20207:00 amRNSResult of Capital Raising
20th Jul 20204:37 pmRNSPrimaryBid.com Offer
20th Jul 20204:35 pmRNSProposed Capital Raising of a minimum of £2m
20th Jul 20202:00 pmRNSCambridge Raman Imaging completes £250,000 funding
14th Jul 20207:00 amRNSAquaInSilico wins grant to commercialise software
13th Jul 20207:00 amRNSPulsiv demonstrates strong progress
7th Jul 20207:00 amRNSCelerum supports development for PlanSea Solutions
6th Jul 20207:00 amRNSBosch collaboration with Fieldwork
30th Jun 20205:00 pmRNSTotal Voting Rights
23rd Jun 20207:00 amRNSThe Vaccine Group: strong COVID-19 progress
17th Jun 20207:00 amRNSCambridge & FIPP collaborate to tackle gum disease
28th May 20207:10 amRNSPortfolio news: Access to Elute's Patent Reader
28th May 20207:00 amRNSExercise of Options and Total Voting Rights
26th May 20207:00 amRNSPortfolio news – Exscientia raises $60 million
7th May 20207:00 amRNSExscientia and SRI International collaborate
1st May 20207:00 amRNSPortfolio news – Molendotech raises £425,000
15th Apr 20207:00 amRNSPortfolio news – Pulsiv Solar awarded patent
9th Apr 20207:00 amRNSPortfolio news: Alusid launches luxury Block range
6th Apr 202012:01 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSExscientia announces joint initiative re COVID-19
30th Mar 20204:40 pmRNSSecond Price Monitoring Extn
30th Mar 20204:36 pmRNSPrice Monitoring Extension
30th Mar 20207:00 amRNSElute Intelligence’s AI to back COVID-19 research
26th Mar 20207:00 amRNSPortfolio news: new portfolio company AquaInSilico
25th Mar 20207:00 amRNSUnaudited Half Year Results
19th Mar 20207:00 amRNSFrontier partners University of Lisbon competition
17th Mar 20203:15 pmRNSNotice of interim results
13th Mar 20207:00 amRNSPortfolio news – The Vaccine Group Update
12th Mar 202011:05 amRNSSecond Price Monitoring Extn
12th Mar 202011:00 amRNSPrice Monitoring Extension
19th Feb 202012:37 pmRNSHolding(s) in Company
17th Feb 20207:00 amRNSCRIL wins EUR140,000 EU Graphene Flagship funding
12th Feb 20207:00 amRNSPortfolio news - FIPP increases stake in Celerum
31st Jan 20207:00 amRNSPortfolio news - Exscientia
20th Jan 20207:00 amRNSPortfolio news - The Vaccine Group raises £680,000
16th Jan 20203:28 pmRNSHolding(s) in Company
14th Jan 20207:00 amRNSFieldwork Robotics secures first equity funding
10th Jan 20207:00 amRNSExscientia enters collaboration with Bayer AG
31st Dec 20191:00 pmRNSTotal Voting Rights
16th Dec 201910:36 amRNSExercise of Options and Issue of Equity
11th Dec 20196:03 pmRNSHolding(s) in Company
9th Dec 20193:25 pmRNSHolding(s) in Company
9th Dec 20193:21 pmRNSHolding(s) in Company
9th Dec 20192:08 pmRNSHolding(s) in Company
9th Dec 20199:46 amRNSHolding(s) in Company
9th Dec 20197:00 amRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.